U3-1784

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameU3-1784

Drug Alias NameU3-1784

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionFibroblast growth factor receptor 4 antagonists

TargetsFibroblast growth factor receptor 4

Therapy Area/IndicationsSolid tumoursLiver Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesU3 Pharma

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsSolid tumoursLiver Neoplasms

ATC CodeN/A